Skip to main content
. 2007 May 15;64(3):292–303. doi: 10.1111/j.1365-2125.2007.02899.x

Table 1.

Arithmetic mean PK parameters of dabigatran after single dose oral administration (10–400 mg dabigatran etexilate) and after multiple dose administration (50–400 mg dabigatran etexilate three times daily)

Dose of dabigatran etexilate (mg)
Single dose study Multiple dose study
Parameter 10 (n = 6) 30 (n = 6) 100 (n = 6) 200 (n = 6) 400 (n = 6) 50 (n = 7–8) 100 (n = 8) 200 (n = 8) 400 (n = 8)
Cmax (ng ml−1) 8.3 21.5 82.2 161.0 344.0 42.6 128.0 199.0 303.0
(CV%) (30.1) (42.7) (30.0) (28.1) (39.4) (42.1) (46.2) (15.6) (29.6)
tmax* (h) 1.25 1.25 1.50 1.50 1.50 1.25 1.50 1.50 1.25
Cmax,ss (ng ml−1) 64.3 191.0 359.0 697.0
(CV%) (34.6) (20.5) (14.6) (33.0)
Cmin,ss (ng ml−1) 18.1 56.9 105.0 224.0
(CV%) (31.1) (33.2) (21.4) (33.7)
tmax,ss (h) 1.5 1.5 1.5 1.5
t1/2 (h) 7.1 8.4 8.9 7.3 14.0 17.2 16.4
(CV%) (11.9) (12.9) (9.4) (13.6) (32.3) (19.2) (15.5)
AUC(0,∞) (ng ml−1 h) 548 1110 2380
(CV%) (31.5) (26.7) (40.3)
AUC(0,8 h) (ng ml−1 h) 165 552 821 1290
(CV%) (33.7) (45.3) (16.5) (32.4)
AUCss (ng ml−1 h) 305 904 1620 3270
(CV%) (32.6) (25.5) (18.5) (32.3)
MRTtot (h) 8.7 9.6 10.3
(CV%) (11.3) (15.3) (10.2)
MRTss (h) 9.0 10.6 10.1 11.0
(CV%) (12.8) (11.0) (7.67) (10.7)
CLtot/F (ml min−1) 2430 2390 2410 2260 1480 1590 1660
(CV%) (23.7) (26.6) (39.2) (33.9) (28.4) (17.4) (28.8)
Vz/F (l) 1470 1720 1830 1430 1840 2390 2400
(CV%) (21.7) (23.9) (36.8) (36.1) (48.1) (31.7) (35.1)
*

Median.